William Blair analyst Sami Corwin reiterated an Outperform rating on Neurogene (NASDAQ: NGNE)The analyst commented, "We view Neurogene’s continued progress ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE